2012-2015
Founded as a Patient Advocacy Organization, dedicated to improving access to modern treatments in underserved regions.
2016
Transitioned into a full-service Contract Research Organization (CRO), partnering with global sponsors for clinical development.
2018
Expanded into multi-regional clinical trials (MRCTs), strengthening regulatory collaborations worldwide.
2020
Broadened global operational reach through strategic alliances with partner CROs and CDMOs.
2022
Introduced Contract Development & Manufacturing Organization (CDMO) services, specializing in generics & hybrid product development for regulated markets.
2023-Present
Present – Rebranded as DRK Research Solutions SA, headquartered in Switzerland, with an active footprint across Europe, the Middle East, Asia, Africa, and the Americas.